I’ve been in this stock since 2020 and I’ve done a ton of research on their intranasal ketamine. Patent pending in the states, international patents in place. This is a dual enantiomer ketamine, low dose, non-invasive method of administration. Their stage 2 trial has wrapped up with readout expected mid-September of this year. Read: 3 years guaranteed exclusivity prior to patent approval.
There is hardly any volume in this stock. Almost a hundred institutions own shares and there are several more drugs in the pipeline including a patented version of trelahous for ALS. Am I missing something here? How is this so under the radar?
[link] [comments] https://www.reddit.com/r/stocks/comments/14ysb9w/seelos_therapeutics_seel_volume_so_low_why/
Войдите, чтобы добавить комментарий
Другие сообщения в этой группе
Please use this thread to discuss your portfolio, learn of other stock tickers, and help out users by giving constructive criticism.
Why quarterly? Public comp
When you sell a stock to buy another stock, do you prefer to set the estimated amount of the capital gains taxes aside in a money market or do you think it better to
Saving for retirement is crucial, but relying solely on a 401(k) might not be enough due to high inflation. Consider investing in growth stocks, especially in the tec
I’m think this is not a good investment as there is no chatter at all on the 52 week low. They are involved in a class action lawsuits by investors and credit card co
Sorry if this is the wrong sub. Let’s say I had $1 million in VOO but I wanted to sell half of it to buy SCHD. It would suck to pay taxes on $500k. So how would you g
Hey guys, I did a deep dive into Crocs. In this analysis, I will do a brief breakdown of the company and go over some quantitative data, qualitative data and estimate
